| ALL | acute lymphoblastic leukemia |
| anti-Xa | anti-factor Xa activity |
| aPTT | activated partial thromboplastin time |
| ASH | American Society of Hematology |
| COVID-19 | coronavirus disease 2019 |
| CSVT | cerebral sinovenous thrombosis |
| CT | computed tomography |
| CTPA | computed tomography pulmonary angiography |
| CVC | central venous catheter |
| DOAC | direct oral anticoagulant |
| DVT | deep vein thrombosis |
| FFP | fresh-frozen plasma |
| INR | international normalized ratio |
| ISTH | International Society on Thrombosis and Haemostasis |
| IU | international unit |
| IVC | inferior vena cava |
| LMWH | low-molecular-weight heparin |
| MIS-C | multisystem inflammatory syndrome in children |
| MRI | magnetic resonance imaging |
| MRV | magnetic resonance venography |
| NICU | neonatal intensive care unit |
| PCC | prothrombin complex concentrate |
| PE | pulmonary embolism |
| PICC | peripherally inserted central catheter |
| PTS | post-thrombotic syndrome |
| RVT | renal vein thrombosis |
| SARS-CoV-2 | severe acute respiratory syndrome coronavirus 2 |
| tPA | tissue plasminogen activator |
| UFH | unfractionated heparin |
| VKA | vitamin K antagonist |
| VTE | venous thromboembolism |